News & Events

Distinguishing features of Long COVID identified through immune profiling
A very relevant Mount Sinai-Yale Long COVID (MY-LC) paper has just been published by Nature. In this publication, more than …
Trial By Error: An Interview with Yale’s Akiko Iwasaki
Very interesting interview with Professor Akiko Iwasaki, a professor of immunobiology at the Yale School of Medicine and a leading Long …
EPI-WIN webinar: Global Update on COVID-19: managing the risks from new variants (27 of September 2023, 13:15h – 14:15h)
Although COVID-19 is no longer a public health emergency of international concern, it remains a public health threat, and the number of …
New Orchestra project publication: How European research projects can support vaccination strategies
Within the H2020 ORCHESTRA project, four studies have been formulated with different cohorts from a total of 18 countries worldwide, …
Long covid: the doctors’ lives destroyed by an illness they caught while doing their jobs
"The ONS data estimates that up to 4.41% of healthcare workers have acquired Long COVID." "These are doctors left at risk and …
New TLC Sesssions -Living with Long Covid: Talk with Dr. Eric Topol
Do not miss this very interesting talk with Dr. Eric Topol, MD, cardiologist, prolific Long COVID author and one of the …
What level of risk is posed by a new wave of COVID-19 cases?
Aljazeera's Inside Story on how dangerous the new wave of COVID-19. Between July and August, the World Health Organization records 1.4 million new …
Wait goes on for effective long Covid treatments
"Unlike the vaccine race, there is limited funding to treat a condition that is often debilitating." "While long Covid is …
Long COVID: The hunt for causes and cures
Excellent article by Shi En Kim published in Chemical & Engineering News on the main challenges of finding treatment for Long COVID. This …
Illuminating Long Covid: Ground Truths Podcast with Ziyad Al-Aly and Eric Topol
Do not miss this extraordinary conversation on Long COVID between Dr. Eric Topol (professor, molecular medicine, executive vice-president of Scripps Research, …
Long COVID round table (12th September 2023)
In the frame of the Initiative Long COVID, launched by German Federal Ministry of Health (Bundesministeriums für Gesundheit, BMG), on …
The Long COVID Initiative of the German Federal Ministry of Health
The German Federal Ministry of Health (Bundesministeriums für Gesundheit, BMG) launched in July 2023 the initiative Long COVID: Comprehensive support …
BY-COVID: Research Data Management Training – Preparing to manage your data across disciplines
The EU-funded BY-COVID project aims to make COVID-19 data accessible to scientists in laboratories but also to anyone who can use it, …
Humoral immunity to an endemic coronavirus is associated with postacute sequelae of COVID-19 in individuals with rheumatic diseases
Why do some people infected with COVID-19 develop postacute sequelae of COVID-19 (PASC) while others do not? This is the …
SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)
Very interesting position paper led by Dr. Amy Proal reviewing studies that have identified SARS-CoV-2 RNA/protein or immune responses indicative of a SARS-CoV-2 reservoir in post-acute …
The Mystery of Long COVID Is Just the Beginning
Do not miss this very interesting article published by The Intelligencer (New York Magazine) about Lisa Sanders, internal-medicine doctor at Yale …
Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization
A new prospective cohort study published by Nature Medicine (Nature Portfolio) on Long COVID. From more than 1,800 adults hospitalized with …
Q&A: Long COVID study sees ‘very sobering’ results after 2 years
Ziyad Al-Aly, chief of research and development at the Veterans Affairs St. Louis Health Care System and a clinical epidemiologist …
Long COVID in low-income and middle-income countries: the hidden public health crisis
New publication in the Lancet. "The COVID-19 pandemic exposed crucial fault lines in society both within and between different societies. …
Persistent symptoms after COVID-19 are not associated with differential SARS-CoV-2 antibody or T cell immunity
This study led by the Imperial College London was recently published by Nature Communications. In the study, SARS-CoV-2 humoral and …
1 2 3 4 5 24 25 26 27